)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
ABVC BioPharma
ABVC BioPharma (ABVC) investor relations material
ABVC BioPharma Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary18 May, 2026
Executive summary
Focused on plant-derived drug and device development, with clinical programs in CNS, oncology, and ophthalmology, and a CDMO services subsidiary.
No revenue recognized in Q1 2026; operations funded by equity, debt, and related party support.
Strategic land acquisitions in Taiwan to support future R&D and manufacturing.
Financial highlights
Net loss of $1.69 million for Q1 2026, up 79% year-over-year from $0.94 million in Q1 2025.
Operating expenses rose 127% to $1.57 million, mainly due to increased stock-based compensation.
Net cash used in operating activities was $894,243, with a working capital deficit of $4.74 million as of March 31, 2026.
Cash and cash equivalents at quarter-end were $140,324.
Outlook and guidance
Management plans to improve liquidity through licensing collections, new financings, cost controls, and debt reduction.
Ongoing integration of affiliates and expansion of CDMO platform expected to support future cash flows.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ABVC BioPharma
- Shareholders will vote on director re-elections, auditor ratification, and an equity plan increase.ABVC
Proxy Filing5 Mar 2026 - Net loss increased to $8.4M in 2025 with no revenue recognized and ongoing going concern risks.ABVCQ4 20253 Mar 2026
- Shareholders will vote on director re-elections, auditor ratification, and an equity plan increase.ABVCProxy Filing5 Feb 2026
- Plant-based drug developer seeks up to $100M via shelf registration amid global expansion.ABVCRegistration Filing16 Dec 2025
- Proxy covers board elections, auditor ratification, equity plan changes, and related party land deal.ABVCProxy Filing2 Dec 2025
- Shareholders will vote on director re-elections, auditor ratification, land purchase, equity plan, and reverse split.ABVCProxy Filing2 Dec 2025
- Biotech firm registers 1M shares for resale amid ongoing losses and significant operational risks.ABVCRegistration Filing29 Nov 2025
- Q3 2025 licensing revenue and assets soared, but losses and liquidity risks persist.ABVCQ3 20253 Nov 2025
- Q3 2024 revenue surged 2,351% and first operational profit was achieved as net loss narrowed 96%.ABVCQ3 20249 Oct 2025
Next ABVC BioPharma earnings date
Q2 202613 Aug, 2026
ABVC BioPharma
Next ABVC BioPharma earnings date
Q2 202613 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage